enGene Therapeutics, Inc. (ENGN)
1.80
+0.03
(+1.69%)
USD |
NASDAQ |
Sep 11, 16:00
1.79
-0.01
(-0.56%)
After-Hours: 06:28
enGene Therapeutics Total Liabilities (Quarterly) : 58.03M for July 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 58.03M |
| April 30, 2026 | 52.36M |
| January 31, 2026 | 55.57M |
| October 31, 2025 | 53.76M |
| July 31, 2025 | 44.88M |
| April 30, 2025 | 39.36M |
| January 31, 2025 | 35.98M |
| October 31, 2024 | 38.56M |
| July 31, 2024 | 36.55M |
| April 30, 2024 | 30.56M |
| January 31, 2024 | 31.04M |
| Date | Value |
|---|---|
| October 31, 2023 | |
| September 30, 2023 | 15.37M |
| July 31, 2023 | 0.0725M |
| June 30, 2023 | 11.73M |
| March 31, 2023 | 6.49M |
| December 31, 2022 | 4.621M |
| September 30, 2022 | 4.403M |
| June 30, 2022 | 4.330M |
| March 31, 2022 | 4.251M |
| December 31, 2021 | 4.055M |
| September 30, 2021 | 0.3404M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 177.40M |
| Medicus Pharma Ltd. | 20.33M |
| Xenon Pharmaceuticals, Inc. | 53.38M |
| Psyence Biomedical Ltd. | 0.9431M |
| Geron Corp. | 300.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 288.32M |
| Shareholders Equity (Quarterly) | 230.29M |
| Debt to Equity Ratio | 0.1445 |
| Current Ratio | 10.21 |
| Net Debt Paydown Yield | -1.32% |